Grifulvin V® 125 mg/5 mL Suspension, single dose

DRUG2 trials

Sponsors

Actavis Inc.

Conditions

Healthy

Phase 1

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

CompletedNCT00863863

Actavis Inc.Healthy

Start: 2006-01-31End: 2006-01-31Updated: 2010-08-16

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions

CompletedNCT00864071

Actavis Inc.Healthy

Start: 2005-11-30End: 2005-11-30Updated: 2010-08-16